Examining the Long-term Clinical Evidence of Therapies for Inflammatory Bowel Disease in Bio-naïve Patients : Episode 17

Video

July 26, 2023

Biosimilar Treatment Options for Patients With UC

Author(s):

David P. Hudesman, MD,Maia Kayal, MD

Experts discuss the recent use of biosimilars like inolimomab as treatment for ulcerative colitis (UC).

EP: 1.Overview of IBD

EP: 2.Treatment Factors of IBD

EP: 3.Managing Care for IBD Patients Not Responding to Treatment

EP: 4.Selecting First-Line Treatments for CD

EP: 5.The Role of Vedolizumab and Risankizumab in CD

EP: 6.Efficacy and Safety of Ustekinumab for CD

EP: 7.Selecting Therapies for CD in Pregnancy

EP: 8.Selecting Treatments in Patients With EIM

EP: 9.Second-Line Therapies for CD

EP: 10.Optimizing Therapies for CD

EP: 11.Major Takeaways for Treating CD

EP: 12.Treatment Approaches for Patients With UC

EP: 13.The Role of Ozanimod in UC

EP: 14.The Role of Ustekinumab in UC

EP: 15.Utilizing JAK Inhibitors in Patients With UC

EP: 16.Treatment Sequencing for UC

EP: 17.Biosimilar Treatment Options for Patients With UC

EP: 18.Key Takeaways and Prospective Treatment Advances

Related Videos

Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS

Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD

$Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD$

Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.